The U.S. vaccines market is expected to grow from USD 22.23 billion in 2024 to USD 34.64 billion by 2032, at a CAGR of 5.70%. This growth is driven by strong healthcare infrastructure, high immunization coverage, and continued R&D investments—especially in mRNA and next-generation vaccine technologies.
Click – https://www.marketsandata.com/industry-reports/united-states-vaccines-market
Market Drivers
- Strong Ecosystem: The presence of major pharmaceutical companies like Pfizer, Moderna, and Merck, combined with government programs (e.g., Vaccines for Children), ensures wide access and robust vaccine rollout.
- Tech Innovation: AI, nanotechnology, cell-based manufacturing, and tools like CRISPR are accelerating vaccine development, improving production efficiency, and expanding treatment capabilities.
- Public-Private Funding: Government initiatives such as Operation Warp Speed and NIH/BARDA support, along with private investment, are fueling rapid vaccine advancements.
- Chronic Disease Prevalence: Rising rates of diabetes, cancer, and respiratory issues are increasing demand for both preventive and therapeutic vaccines.
Key Developments
- In 2023, the FDA approved CYFENDUS, an anthrax vaccine, and in 2024, Pfizer’s ABRYSVO was cleared for infant respiratory protection.
- The University at Buffalo developed a Nano-liposome-based flu vaccine, showing the shift toward innovative delivery systems.
- CSL Limited opened a new 54,000 sq. ft. vaccine R&D center in Massachusetts.
Outlook (2025–2032)
The U.S. market will continue expanding due to growing vaccine needs tied to aging, chronic illnesses, and emerging diseases. Biotech innovation and strong financial backing will drive the development of safer, faster, and more targeted vaccines across various age groups and health conditions.
Latest reports-
https://www.marketsandata.com/industry-reports/united-states-golf-shoes-market
https://www.marketsandata.com/industry-reports/aircraft-component-market
Contact
Mr. Vivek Gupta
5741 Cleveland street,
Suite 120, VA beach, VA, USA 23462
Tel: +1 (757) 343–3258
Email: info@marketsandata.com
Website: https://www.marketsandata.com
Comments
0 comment